CI Platform
Sign in
Aspira Women's Health Inc.AWHLNYSE NAS ASE FRA
Current ReportFundamental Reports

North America / UNITED STATES

Report Sections1

Available for this company

Reporting UnitMillions

NYSE NAS ASE FRA

Company Overview

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryDiagnostic Substances
CountryUNITED STATES
Employees38
Reporting UnitMillions
Primary ExchangeNYSE NAS ASE FRA
Instrument TypeEquity
Websitehttp://aspirawh.com
Wright IDC840XGFBC

Key Metrics

Current price$0.23
Market cap$10.6 M
P/E ration/a
52-week perf.-52.8%
Common shares46.6 M
Closely held5.5 M
Share typeCommon
Quality ratingLLL0
Dividend yield0.00%

Recent stock performance

1 Week+7.9%
4 Week-4.7%
13 Week-35.3%

Officers

Non Executive ChairmanDr. Veronica G. H. Jordan
President & Chief ExecutiveNicole Sandford
Chief Operating OfficerDr. Ryan Phan
Chief Financial OfficerDr. Torsten Hombeck
Secretary & General CounselMinh Merchant

Address

12117 Bee Caves Road Building Three

AUSTIN, TEXAS

UNITED STATES

78738

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.